Citation: | XIE Yuan, WANG Hong, FENG Dong, HAO Haiping, WANG Guangji. Influence of curcumin on the pharmacokinetics of lovastatin in rats with fatty liver disease[J]. Journal of China Pharmaceutical University, 2013, 44(6): 543-547. DOI: 10.11665/j.issn.1000-5048.20130611 |
[1] |
Rivera-Espinoza Y,Muriel P.Pharmacological actions of curcumin in liver diseases or damage[J].Liver Int,2009,29(10):1 457-1 466.
|
[2] |
Shao W,Yu Z,Chiang Y,et al.Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes[J].PLoS One,2012,7(1):e28784.
|
[3] |
Kuo JJ,Chang HH,Tsai TH,et al.Curcumin ameliorates mitochondrial dysfunction associated with inhibition of gluconeogenesis in free fatty acid-mediated hepatic lipoapoptosis[J].Int J Mol Med,2012,30(3):643-649.
|
[4] |
Kuo JJ,Chang HH,Tsai TH,et al.Positive effect of curcumin on inflammation and mitochondrial dysfunction in obese mice with liver steatosis[J].Int J Mol Med,2012,30(3):673-679.
|
[5] |
Cheng PY,Wang M,Morgan ET.Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin[J].J Pharmacol Exp Ther,2003,307(3):1 205-1 212.
|
[6] |
Chauvin B,Drouot S,Barrail-Tran A,et al.Drug-drug interactions between HMG-CoA reductase inhibitors(Statins)and antiviral protease inhibitors[J].Clin Pharmacokinet,2013,May 24.[Epub ahead of print].
|
[7] |
Sun JG,Wang GJ,Xie L,et al.Rapid LC-MS determination and pharmacokinetic research of lovastatin in dog plasma[J].Chin J Pharm Anal(药物分析杂志),2006(1):44-47.
|
[8] |
Park JS,Seo JH,Youn HS.Gut microbiota and clinical disease:obesity and nonalcoholic Fatty Liver disease[J].Pediatr Gastroenterol Hepatol Nutr,2013,16(1):22-27.
|
[9] |
Salem NA,Assaf N,Ahmed HH.Pleiotropic effects of rimonabant and simvastatin on obesity associated multiple metabolic risk factors in rats[J].Eur Rev Med Pharmacol Sci,2012,16(6):797-807.
|
[10] |
Schaalan MF.Effects of pioglitazone and/or simvastatin on circulating TNFα and adiponectin levels in insulin resistance[J].J Immunotoxicol,2012,9(2):201-209.
|
[11] |
Patoine D,Levac X,Pilote S,et al.Decreased CYP3A expression and activity in guinea pig models of diet-induced metabolic syndrome:is fatty liver infiltration involved[J].Drug Metab Dispos,2013,41(5):952-957.
|
[1] | CHEN Feihong, ZHAO Deming, GOU Shaohua. Research progress on the antitumor effects of platinum-based chemo-immunotherapies[J]. Journal of China Pharmaceutical University, 2024, 55(1): 26-35. DOI: 10.11665/j.issn.1000-5048.2023120201 |
[2] | XU Yungen. Advances in drug development based on immunoregulation[J]. Journal of China Pharmaceutical University, 2024, 55(1): 1-4. DOI: 10.11665/j.issn.1000-5048.2024022601 |
[3] | YU Dongmei, GUO Wei, LEI Wen, GE Yaoyao, CHEN Yucong, GAO Xiangdong, YAO Wenbing. Advances of lncRNA in immune cells and autoimmune diseases[J]. Journal of China Pharmaceutical University, 2017, 48(3): 371-376. DOI: 10.11665/j.issn.1000-5048.20170319 |
[4] | LIANG Xiao-qing, SHI Chen-yang, WANG Ke, HE Xin, LIU Si-guo, HUANG Xiao-feng, LIU Yu. Anti-angiogenesis and anti-tumor activity of the fully human anti-VEGF165 monoclonal antibody obtained from the five-feature transgenic mice[J]. Journal of China Pharmaceutical University, 2012, 43(6): 560-566. |
[5] | Tumor microenvironment:A novel target for antitumor activity of polysaccharides[J]. Journal of China Pharmaceutical University, 2010, 41(1): 1-10. |
[8] | Effects of Mixed Nucleotide on Acute Hepatic Injury and Immunoregulation in Mice[J]. Journal of China Pharmaceutical University, 2001, (6): 44-47. |
[9] | Immunomodulating Activity of Yang Zheng He Ji[J]. Journal of China Pharmaceutical University, 1995, (1): 37-40. |
[10] | The Immunoregulative Effect of the Synthetic Artifact of Royel Jelly Acid[J]. Journal of China Pharmaceutical University, 1991, (2): 117-118. |